| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | NOTV Inotiv, Inc. | Downing Philip A | Sr. VP, Preclinical Srvcs. | Sell | 3,057 | $43.04 | $131,576.95 | -7.1% | -46.4% | -89.9% | |
| Dec 22, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 57,093 | $218.81 | $12,492,357.61 | -0.5% | -25.0% | -4.7% | |
| Dec 22, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 57,093 | $218.81 | $12,492,357.61 | -0.5% | -25.0% | -4.7% | |
| Dec 21, 2021 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 12,000 | $92.98 | $1,115,731.86 | -6.5% | -58.7% | -56.3% | |
| Dec 21, 2021 | TWST Twist Bioscience Corp | Weiss Patrick86 | Chief Operating Officer | Sell | 3,918 | $82.85 | $324,606.30 | -8.3% | -45.3% | -71.9% | |
| Dec 21, 2021 | NEO Neogenomics Inc | McKenzie Kathryn B | Chief Financial Officer | Sell | 1,846 | $35.00 | $64,610.00 | -13.6% | -50.7% | -72.2% | |
| Dec 21, 2021 | TWST Twist Bioscience Corp | Finn Patrick John73 | Chief Commercial Officer | Sell | 219 | $82.85 | $18,144.15 | -0.6% | -45.3% | -71.9% | |
| Dec 20, 2021 | BDSX Biodesix Inc | Watts Charles M | Director | Buy | 5,855 | $4.29 | $25,132.00 | +292.8% | -54.4% | -57.1% | |
| Dec 20, 2021 | A Agilent Technologies, Inc. | McMullen Michael R.63 | CEO And President | Sell | 123,459 | $148.82 | $18,373,168.38 | -39.2% | -8.0% | -1.0% | |
| Dec 20, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 53,339 | $213.16 | $11,369,488.33 | -0.5% | -23.2% | -4.7% | |
| Dec 20, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 53,339 | $213.16 | $11,369,488.33 | -0.5% | -23.2% | -4.7% | |
| Dec 17, 2021 | VCYT Veracyte, Inc. | Eastham Karin65 | Director | Sell | 5,000 | $45.00 | $225,000.00 | -36.4% | -38.7% | -39.1% | |
| Dec 17, 2021 | PSNL Personalis, Inc. | West John Stephen91 | President And CEO | Sell | 2,732 | $12.80 | $34,969.60 | -0.7% | -42.0% | -85.3% | |
| Dec 17, 2021 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 3,437 | $12.80 | $43,993.60 | -1.3% | -42.0% | -85.3% | |
| Dec 17, 2021 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 1,563 | $12.80 | $20,006.40 | -1.0% | -42.0% | -85.3% | |
| Dec 17, 2021 | XWEL Xwell, Inc. | Bernstein Bruce58 | Director | Buy | 37,500 | $1.70 | $63,889.00 | +1.8% | -15.2% | -75.7% | |
| Dec 16, 2021 | RVTY Revvity, Inc. | Okun Andrew76 | Please See Remarks | Sell | 1,350 | $189.04 | $255,205.54 | -3.6% | -6.2% | -26.6% | |
| Dec 16, 2021 | PSNL Personalis, Inc. | West John Stephen91 | President And CEO | Sell | 97,268 | $13.42 | $1,305,336.56 | -20.0% | -37.3% | -83.3% | |
| Dec 16, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 8,383 | $210.24 | $1,762,419.70 | - | -26.6% | -1.7% | |
| Dec 16, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 8,383 | $210.24 | $1,762,419.70 | - | -26.6% | -1.7% | |
| Dec 15, 2021 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 25,000 | $85.20 | $2,130,096.89 | -1.3% | -54.8% | -71.6% | |
| Dec 15, 2021 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 10,000 | $26.81 | $268,060.00 | -3.5% | -25.0% | -29.5% | |
| Dec 14, 2021 | TWST Twist Bioscience Corp | Weiss Patrick86 | Chief Operating Officer | Sell | 2,801 | $84.00 | $235,284.00 | -5.6% | -54.2% | -68.5% | |
| Dec 10, 2021 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 10,000 | $27.18 | $271,800.00 | -3.3% | -22.4% | -26.7% | |
| Dec 10, 2021 | GH Guardant Health, Inc. | Meresman Stanley J75 | Director | Sell | 4,934 | $95.59 | $471,641.06 | -54.9% | -37.5% | -50.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.